Related Experiment Video
Updated: Mar 2, 2026

07:07
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
3.9K
SU-E-J-196: In-Vivo Tumor Blood-Oxygen Content Measurement via Interstitial Optical Transmission Spectroscopy
Medical Physics
|May 19, 2017
Summary
This study demonstrates in-vivo diffuse optical transmission spectroscopy to measure tumor oxygen saturation and reoxygenation dynamics during radiotherapy. The technique quantifies hemoglobin concentrations, offering insights into tumor response to radiation injury.
Area of Science:
- Biomedical Optics
- Cancer Research
- Medical Physics
Background:
- Hypoxia in tumors impacts radiotherapy efficacy.
- Real-time monitoring of tumor oxygenation is crucial for treatment optimization.
- Diffuse optical transmission spectroscopy offers a non-invasive method for tissue analysis.
Purpose of the Study:
- To apply in-vivo diffuse optical transmission spectroscopy for quantifying interstitial tissue oxygen saturation.
- To investigate real-time tumor reoxygenation dynamics in response to radiotherapy.
- To assess the potential of this technique for optimizing hypofractionated radiation therapies.
Main Methods:
- Utilized fiber optics inserted via hypodermic needles into human head-and-neck tumor xenografts in nude mice.
- Employed a spectrometer and light source to measure transmission spectra.
- Quantified oxygen saturation and hemoglobin concentrations at various time points post-irradiation.
Main Results:
- Successfully measured blood volume, deoxyhemoglobin, and oxyhemoglobin concentrations through spectral fitting.
- Explored different interstitial fiber optic probe configurations to enhance signal strength.
- Identified improved optical coupling and increased source intensity as key factors for signal improvement.
Conclusions:
- The technique provides insights into the temporal dynamics of hypoxia and reoxygenation in tumors during radiation therapy.
- This method is particularly valuable for hypofractionated treatments, enabling optimized timing for increased tumoricidal effects.
- Further development can enhance signal strength for more robust in-vivo measurements.

